Author

G. E. Foxa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Assay:ChIP-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

B. K. Johnson· 1 shared B. O. Williams· 1 shared E. A. Boguslawski· 1 shared I. Beddows· 1 shared K. M. Sorensen· 1 shared L. Heo· 1 shared M. H. Chasse· 1 shared P. J. Grohar· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. K. Johnson

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Direct therapeutic targeting of SWI/SNF induces epigenetic reprogramming and durable tumor regression in rhabdoid tumor

M. H. Chasse, B. K. Johnson, E. A. Boguslawski, K. M. Sorensen, L. Heo, Z. B. Madaj, I. Beddows, G. E. Foxa, S. M. Kitchen-Goosen, B. O. Williams, T. J. Triche, P. J. Grohar

This paper shows that targeting the SWI/SNF complex with mithramycin and its analogue EC8042 induces epigenetic reprogramming and durable tumor regression in rhabdoid tumors.

bioRxiv · Dec 3, 2019 · PreprintCancer Biology